Percutaneous papillary muscle relocation

US10799356B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10799356-B2
Application numberUS-201816116307-A
CountryUS
Kind codeB2
Filing dateAug 29, 2018
Priority dateSep 12, 2017
Publication dateOct 13, 2020
Grant dateOct 13, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A mitral regurgitation treatment system may include an annuloplasty device configured for placement on an atrial side of a mitral valve, a tethering element configured to extend between a first papillary muscle and a second papillary muscle, wherein the tethering element includes a first anchor securing the tethering element to the first papillary muscle and a second anchor securing the tethering element to the second papillary muscle, and a linking element extending from the annuloplasty device to the tethering element. The linking element may include a spring element disposed between the annuloplasty device and the tethering element.

First claim

Opening claim text (preview).

What is claimed is: 1. A mitral regurgitation treatment system, comprising: an annuloplasty device configured for placement on an atrial side of a mitral valve; a tethering element configured to extend between a first papillary muscle and a second papillary muscle, wherein the tethering element includes a first anchor securing the tethering element to the first papillary muscle and a second anchor securing the tethering element to the second papillary muscle; and a linking element extending from the annuloplasty device to the tethering element; wherein the linking element includes a spring element disposed between the annuloplasty device and the tethering element; wherein the first anchor includes a first anchoring element configured to be positioned against an outer surface of the first papillary muscle and a second anchoring element configured to be positioned against the outer surface of the first papillary muscle opposite the first anchoring element such that the first papillary muscle is disposed between the first anchoring element and the second anchoring element and a first portion of the tethering element passes through the first papillary muscle; wherein the second anchor includes a third anchoring element configured to be positioned against an outer surface of the second papillary muscle and a fourth anchoring element configured to be positioned against the outer surface of the second papillary muscle opposite the third anchoring element such that the second papillary muscle is disposed between the third anchoring element and the fourth anchoring element and a second portion of the tethering element passes through the second papillary muscle. 2. The mitral regurgitation treatment system of claim 1 , wherein the linking element connects to the tethering element along a length of the tethering element. 3. The mitral regurgitation treatment system of claim 1 , wherein the linking element is configured to connect to the tethering element at a location between the first papillary muscle and the second papillary muscle. 4. The mitral regurgitation treatment system of claim 1 , wherein the spring element maintains the linking element in tension between the annuloplasty device and the tethering element. 5. The mitral regurgitation treatment system of claim 4 , further comprising a crimping element disposed on the linking element and configured to engage an outer surface of the annuloplasty device. 6. The mitral regurgitation treatment system of claim 1 , wherein the linking element extends through the annuloplasty device. 7. The mitral regurgitation treatment system of claim 6 , wherein the linking element extends through the annuloplasty device in a direction generally parallel to fluid flow through the mitral valve. 8. The mitral regurgitation treatment system of claim 1 , wherein the linking element is configured to extend through tissue of the mitral valve. 9. The mitral regurgitation treatment system of claim 1 , wherein the spring element is formed from nitinol. 10. A mitral regurgitation treatment system, comprising: an annuloplasty device configured for placement on an atrial side of a mitral valve; a tethering element configured to extend between a first papillary muscle and a second papillary muscle, wherein the tethering element includes a first anchor securing the tethering element to the first papillary muscle and a second anchor securing the tethering element to the second papillary muscle; and a linking element extending from the annuloplasty device to the tethering element; wherein the first anchor includes a first anchoring element configured to be positioned against an outer surface of the first papillary muscle and a second anchoring element configured to be positioned against the outer surface of the first papillary muscle opposite the first anchoring element such that the first papillary muscle is disposed between the first anchoring element and the second anchoring element and a first portion of the tethering element passes through the first papillary muscle; wherein the second anchor includes a third anchoring element configured to be positioned against an outer surface of the second papillary muscle and a fourth anchoring element configured to be positioned against the outer surface of the second papillary muscle opposite the third anchoring element such that the second papillary muscle is disposed between the third anchoring element and the fourth anchoring element and a second portion of the tethering element passes through the second papillary muscle. 11. The mitral regurgitation treatment system of claim 10 , wherein the linking element is connected to the tethering element between the first portion and the second portion. 12. The mitral regurgitation treatment system of claim 11 , wherein the linking element is slidable along the tethering element. 13. The mitral regurgitation treatment system of claim 10 , wherein at least one of the tethering element and the linking element comprise a multi-strand suture. 14. The mitral regurgitation treatment system of claim 10 , wherein the tethering element is configured to extend between the first papillary muscle and the second papillary muscle in tension. 15. A method of delivering a mitral regurgitation system, comprising: inserting a delivery catheter percutaneously through a vasculature to a left atrium of a heart; deploying an annuloplasty device from the delivery catheter on an atrial side of a mitral valve of the heart; extending a tethering element through the annuloplasty device and into a left ventricle of the heart; anchoring the tethering element to a first papillary muscle; anchoring the tethering element to a second papillary muscle such that the tethering element is in tension between the first papillary muscle and the second papillary muscle; and securing a linking element extending from the tethering element to the annuloplasty device in tension, the linking element including a spring element disposed between the annuloplasty device and the tethering element. 16. The method of claim 15 , wherein extending the tethering element includes extending an anchor delivery catheter from the delivery catheter through the annuloplasty device and into the left ventricle of the heart. 17. The method of claim 15 , wherein anchoring the tethering element to the first papillary muscle includes passing a first portion of the tethering element through the first papillary muscle. 18. The method of claim 15 , wherein anchoring the tethering element to the second papillary muscle includes passing a second portion of the tethering element through the second papillary muscle. 19. The method of claim 15 , wherein securing the linking element includes feeding a crimping element over the linking element and into engagement with the annuloplasty device.

Assignees

Inventors

Classifications

  • A61F2/2445Primary

    Annuloplasty rings in direct contact with the valve annulus · CPC title

  • Chordae tendineae prostheses · CPC title

  • magnetic · CPC title

  • cardiac · CPC title

  • A61F2/2454Primary

    Means for preventing inversion of the valve leaflets, e.g. chordae tendineae prostheses · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10799356B2 cover?
A mitral regurgitation treatment system may include an annuloplasty device configured for placement on an atrial side of a mitral valve, a tethering element configured to extend between a first papillary muscle and a second papillary muscle, wherein the tethering element includes a first anchor securing the tethering element to the first papillary muscle and a second anchor securing the tetheri…
Who is the assignee on this patent?
Boston Scient Scimed Inc
What technology area does this patent fall under?
Primary CPC classification A61F2/2445. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 11 related publications on this page (citations in our corpus or others sharing the same primary CPC).